3 results
Approved WMOCompleted
Does oral simvastatin at standard doses alter BMP pathway signalling in colorectal cancer specimens in humans?
Approved WMOPending
In this study, we look at how safe the new medicinal product XMT-1536 is for the treatment of ovarian cancer and how well it works. We compare the effect of XMT-1536 with the effect of a placebo. A placebo is a product without the active ingredient…
Approved WMOWill not start
To evaluate the safety, tolerability and efficacy of IZD334 to reduce CRP in cardiovascular high-risk patients.